275 related articles for article (PubMed ID: 24472118)
1. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.
Michaud HA; de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF
Retrovirology; 2014 Jan; 11():10. PubMed ID: 24472118
[TBL] [Abstract][Full Text] [Related]
2. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA
Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571
[TBL] [Abstract][Full Text] [Related]
3. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
[TBL] [Abstract][Full Text] [Related]
4. Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.
Gonzalez-Hernandez MJ; Swanson MD; Contreras-Galindo R; Cookinham S; King SR; Noel RJ; Kaplan MH; Markovitz DM
J Virol; 2012 Aug; 86(15):7790-805. PubMed ID: 22593154
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Infection of Primary CD4
Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
[TBL] [Abstract][Full Text] [Related]
6. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.
Contreras-Galindo R; Kaplan MH; Markovitz DM; Lorenzo E; Yamamura Y
AIDS Res Hum Retroviruses; 2006 Oct; 22(10):979-84. PubMed ID: 17067267
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.
Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM
J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938
[TBL] [Abstract][Full Text] [Related]
8. Development of an antigen-capture ELISA for the detection of the p27-CA protein of HERV-K(HML-2).
Hohn O; Mostafa S; Norley S; Bannert N
J Virol Methods; 2016 Aug; 234():186-92. PubMed ID: 27142113
[TBL] [Abstract][Full Text] [Related]
9. Human endogenous retrovirus HERV-K(HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia.
Ehlhardt S; Seifert M; Schneider J; Ojak A; Zang KD; Mehraein Y
J Rheumatol; 2006 Jan; 33(1):16-23. PubMed ID: 16395745
[TBL] [Abstract][Full Text] [Related]
10. Expression of HERV-K108 envelope interferes with HIV-1 production.
Terry SN; Manganaro L; Cuesta-Dominguez A; Brinzevich D; Simon V; Mulder LCF
Virology; 2017 Sep; 509():52-59. PubMed ID: 28605635
[TBL] [Abstract][Full Text] [Related]
11. Human endogenous retrovirus-K(II) envelope induction protects neurons during HIV/AIDS.
Bhat RK; Rudnick W; Antony JM; Maingat F; Ellestad KK; Wheatley BM; Tönjes RR; Power C
PLoS One; 2014; 9(7):e97984. PubMed ID: 24988390
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes.
Brinzevich D; Young GR; Sebra R; Ayllon J; Maio SM; Deikus G; Chen BK; Fernandez-Sesma A; Simon V; Mulder LC
J Virol; 2014 Jun; 88(11):6213-23. PubMed ID: 24648457
[TBL] [Abstract][Full Text] [Related]
13. Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.
Robinson LR; Whelan SP
J Virol; 2016 Jan; 90(7):3640-9. PubMed ID: 26792739
[TBL] [Abstract][Full Text] [Related]
14. TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients.
Simula ER; Arru G; Zarbo IR; Solla P; Sechi LA
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835107
[TBL] [Abstract][Full Text] [Related]
15. Increased HERV-K(HML-2) Transcript Levels Correlate with Clinical Parameters of Liver Damage in Hepatitis C Patients.
Weber M; Padmanabhan Nair V; Bauer T; Sprinzl MF; Protzer U; Vincendeau M
Cells; 2021 Mar; 10(4):. PubMed ID: 33807462
[TBL] [Abstract][Full Text] [Related]
16. Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection.
Vincendeau M; Göttesdorfer I; Schreml JM; Wetie AG; Mayer J; Greenwood AD; Helfer M; Kramer S; Seifarth W; Hadian K; Brack-Werner R; Leib-Mösch C
Retrovirology; 2015 Mar; 12():27. PubMed ID: 25886562
[TBL] [Abstract][Full Text] [Related]
17. Human endogenous retrovirus K (HERV-K) is expressed in villous and extravillous cytotrophoblast cells of the human placenta.
Kämmerer U; Germeyer A; Stengel S; Kapp M; Denner J
J Reprod Immunol; 2011 Sep; 91(1-2):1-8. PubMed ID: 21840605
[TBL] [Abstract][Full Text] [Related]
18. Human endogenous retrovirus HERV-K(HML-2) env expression is not associated with markers of immunosenescence.
Marttila S; Nevalainen T; Jylhävä J; Kananen L; Jylhä M; Hervonen A; Hurme M
Exp Gerontol; 2017 Oct; 97():60-63. PubMed ID: 28774724
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production.
Bhardwaj N; Maldarelli F; Mellors J; Coffin JM
J Virol; 2014 Oct; 88(19):11108-20. PubMed ID: 25056891
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.
Flockerzi A; Ruggieri A; Frank O; Sauter M; Maldener E; Kopper B; Wullich B; Seifarth W; Müller-Lantzsch N; Leib-Mösch C; Meese E; Mayer J
BMC Genomics; 2008 Jul; 9():354. PubMed ID: 18664271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
